Armune BioScience

Armune BioScience

Armune BioScience

Developed the technology APIFINY®—a prostate-cancer-specific non-PSA blood test that may improve decision making when selecting men for prostate biopsies.
Founded
2005
Raised
$18.5M
Follow us
Alexa global traffic share